United States · Series A startup

Who invested in Innervace

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$40Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $40MSept 2022
Investors
2
See who backed them

The rounds

  1. Sept 2022
    Series A$40M

    Source recordedSEC filing: $10.0M sold, first sale Aug 2022

Founders and team

From the SEC filings it signed: 2 on the team.

  • Althea StillmanExecutive Officer, Directori
  • Nader HalimExecutive Officer, Directori

On the board, as filediDavid GreenwaldJonathan Leff

Everyone who backed them

DeerfieldVC firm1round
IP GroupVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Innervace

Who invested in Innervace?

Innervace's investors include Deerfield and IP Group.

How much has Innervace raised?

Innervace has raised $40M across 1 round since 2022.

When did Innervace last raise?

Innervace's most recent round was a Series A of $40M in Sept 2022.

What was Innervace's biggest round?

Its most recent round, $40M in Sept 2022, is also its largest on record.

Who backed Innervace first?

Innervace's first round on record, in Sept 2022, was backed by Deerfield and IP Group.

What stage is Innervace at?

Innervace's latest named round is a Series A, in Sept 2022.

Where is Innervace based?

Innervace is based in the United States.

Companies like Innervace

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.